In this video, 4 innovative companies of French Healthcare specializing in dermatology, ophthalmology and otology are presented.
CILcare is an R&D services company specialized in hearing disorders. On an international market, CILcare proposes to its clients to accelerate the development of their drug candidates by testing their efficacy on preclinical pharmacological models and by supporting them in the preparation of their health product development plans.
Genoskin has developed a platform based on living human skin that enables generating human clinical data to de-risk drug development. Subcutaneous injections can even be tested on this platform to characterize the human immune response in the multiple conditions to be tested.
GenSight Biologics is a clinical-stage biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders. Developed as a treatment for LHON, our lead product candidate LUMEVOQ® is currently under review for MA approval by EMA, and in Phase III to move forward to a BLA filing in the US.
Not just anophtalmology-focused contract research organization (CRO), Iris Pharma helps clients around the world navigate every stage of the drug and medical device development process and delivers customized solutions.